PHARMACY

Roche agrees to conditions for Mircera release

BY Drew Buono

BASEL, Switzerland Roche Holding has agreed to the U.S. District Court for Massachusetts’ conditions in an attempt to gets its anemia drug Mircera on the market, according to the Wall Street Journal.

Last year, a jury concluded that Mircera infringed on numerous patents protecting Amgen’s anemia drugs Aranesp and Epogen. Then, last month the court issued a preliminary injunction but said it might consider allowing Mircera on the market if Roche agreed to some conditions.

One of those conditions states that, Roche will pay Amgen a royalty of 22.5 percent on sales of Mircera, instead of the 20 percent Roche had been willing to pay. Also, Roche agreed to set Mircera’s price at or below Epogen’s for the remainder of the patents that Amgen holds.

According to IMS Health, Aranesp had U.S. sales of $3.2 billion last year and Epogen had sales of $3.1 billion.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

QLT to sell off Aczone following FDA decision

BY Drew Buono

VANCOUVER, Canada QLT has announced that it will proceed with its plan to sell its topical acne treatment Aczone after the Food and Drug Administration removed key blood monitoring requirements for the treatment, according to Reuters.

The company is selling the drug as part of a multi-step process to return it to its core business of treating eye diseases. Recently the company had been delving into acne and prostate cancer treatments.

Already several companies have expressed interest in Aczone and QLT predicts the drug will be sold within the next quarter or two.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Safeway offers Shingles vaccination

BY DSN STAFF

PLEASANTON, Calif. Safeway is offering immunization against Shingles, a disease that commonly affects people over 50 or people with compromised immune systems, at 700 pharmacies in the states of Ark., Calif., Colo., Del., Hawaii, Ind., Ill., Mont., Neb., Nev., Ore., Pa., Texas, Va. ,W.Va. and Wash. The vaccine will be provided on a walk-in basis at in-store pharmacies.

“The only way to prevent against contracting this debilitating disease is to get a single shot. By administering vaccines on site, Safeway is making it easy for anyone to protect themselves,” said Dave Fong, Safeway senior vice president of pharmacy. “Receiving a shingles vaccination is as easy as stopping at the pharmacy during your regular shopping trip.” 

Safeway also offers full-service adult and adolescent immunization services for the prevention of such ailments as tetanus, hepatitis, pneumococcal, meningococcal and more.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?